Delphia (Usa) Inc. Abb Vie Inc. Transaction History

Delphia (Usa) Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $42,226 - $48,629	292 Added 14.66%	2,284 $364,000
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $275,513 - $330,413	1,992 New	1,992 $322,000
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $200,925 - $255,441	1,460 New	1,460 $224,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Delphia (Usa) Inc., based on Form 13F filings with the SEC.

Stay updated on Delphia (Usa) Inc. with notifications on news.